Abstract:Inflammatory bowel disease (IBD) is a group of chronic intestinal inflammatory disorders with a prolonged duration characterized by recurrent relapse and remission. The exact etiology of IBD remains poorly understood despite the identification of relevant risk factors, including individual genetic susceptibility, environmental triggers, and disruption of immune homeostasis. Dysbiosis of the gut microbiota is believed to exacerbate the progression of IBD. Recently, increasing evidence has also linked oral microbiota dysbiosis with the development of IBD. On the one hand, IBD patients show significantly unbalanced composition and function of the oral microbiota known as dysbiosis. On the other, overabundances of oral commensal bacteria with opportunistic pathogenicity have been found in the gut microbiota of IBD patients. Herein, we review the current information on the causative factors of IBD, especially recent evidence of IBD-associated oral microbiota dysbiosis, which has seldom been covered in the previous literature review, highlighting the pathogenic mechanisms of specific oral bacteria in the development of IBD. Ectopic colonization of several oral bacteria, including a subset of Porphyromonas gingivalis, Streptococcus mutans, Fusobacterium nucleatum, Campylobacter concisus, and Klebsiella pneumoniae, may lead to destruction of the intestinal epithelial barrier, excessive secretion of inflammatory cytokines, disruption of the host immune system, and dysbiosis of gut microbiota, consequently aggravating chronic intestinal inflammation. Studying oral microbiota dysbiosis may open future horizons for understanding IBD pathogenesis and provide novel biomarkers for IBD. This review also presents the current treatment and new perspectives for IBD treatment.

Oral microbiota dysbiosis accelerates the development and onset of mucositis and oral ulcers

The Potential Effect of Oral Microbiota in the Prediction of Mucositis During Radiotherapy for Nasopharyngeal Carcinoma

The oral microbiome and oral and upper gastrointestinal diseases

Bacteriome and mycobiome dysbiosis in oral mucosal dysplasia and oral cancer

Role of the microbiome in oral cancer occurrence, progression and therapy

Crosstalk between the oral microbiota, mucosal immunity, and the epithelial barrier regulates oral mucosal disease pathogenesis

The Oral Microbiota: Community Composition, Influencing Factors, Pathogenesis, and Interventions

The Role of Oral Microbiota in Chronic Obstructive Pulmonary Disease

[Oral Microbiome and Systemic Diseases].

New Insights into the Role of Oral Microbiota Dysbiosis in the Pathogenesis of Inflammatory Bowel Disease

Regulatory effects of oral microbe on intestinal microbiota and the illness

Oral microbiome and its relationship with oral cancer

Dental Materials for Oral Microbiota Dysbiosis: an Update

Dental Materials for Oral Microbiota Dysbiosis: An Update.

Role of mucositis in predicting gut microbiota composition in people with cancer

Updated perspectives on the contribution of the microbiome to the pathogenesis of mucositis using the MASCC/ISOO framework

The Interplay Between Oral Microbes and Immune Responses

The oral microbiota and cardiometabolic health: A comprehensive review and emerging insights

Gut microbial dysbiosis and inflammation: Impact on periodontal health

Oral microbiota in human systematic diseases

Oral microbiota: an overlooked etiology for chemotherapy-induced oral mucositis?